Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations


Deby, G., Malanda, C.B., Bossali, F., Atipo-Ibara, B.I., Bokilo-Dzia, A., Ahoui-Apendi, C., et al. (2015) Seroprévalence des marqueurs des virus des hepatites B et C chez le personnel soignant du CHU de Brazzaville. Journal Africain de Hépato-Gastroentérologie, 9, 179-183.

has been cited by the following article:

  • TITLE: Evaluation of Viral Hepatitis B Treatment in Pointe-Noire in 2016

    AUTHORS: F. Bossali, G. Ndziessi, C. L. Ahoui-Apendi, G. Deby, M. J. F. Mimiesse, J. W. Ombila, B. I. Atipo-Ibara, J. R. Ibara

    KEYWORDS: Access, Congo, Hepatitis B, Pointe-Noire, Treatment

    JOURNAL NAME: International Journal of Clinical Medicine, Vol.9 No.6, June 13, 2018

    ABSTRACT: Prevalence of hepatitis B in Pointe-Noire is 23%. The objective of this study was to evaluate the level of therapeutic management of patients with hepatitis B in Pointe-Noire. Methods: A retrospective, cross-sectional, descriptive and analytical study. Results: 302 patients included: 217 (72%) men and 85 (28%) women of median age 40 years. The viral load was measured in 140 (46%) patients and in 162 (54%), the viral load was not measured. Their distribution according to the viremia was as follows: 0 - 1 log = 1 (0.7%) patients; 1.5 to 2 log = 23 (16%) patients; 2.5 to 3 log = 49 (35%) patients; >3log = 55 (39%) patients. Of the 302 patients included, 36 (11%) patients were treated with antivirals and 253 (83%) patients were not. Conclusion: The number of patients treated for chronic viral hepatitis B was low. Our results show interest for improved preventive and curative management of hepatitis B in Congo in order to reduce the existing high prevalence.